Two new pivotal Chinese first-line trials have started in lung cancer.
ApexOnco Front Page
Recent articles
AZD0120’s first pivotal trial will test settings as early as the second line.
Four deaths cast doubt on J&J’s multi-pronged KLK2 push.
A July meeting with the FDA could determine whether Agenus’s bot-bal combo has a shot at a 2024 filing.
The young company’s eighth licensing deal brings in two RAS-targeting projects from Joyo.
The conference’s abstract drop features ASC4First in its plenary session.
The company scraps its lead project and clears out its C-suite, but there was already a precedent.
An early study of the group’s anti-CD47 project SL-172154 has seen waning efficacy, a heart attack and a death.